Phase 3 trials extended to 68 weeks confirmed continued weight loss (28.7% at 68 weeks vs 24.2% at 48 weeks on the 12mg dose)
Retatrutide vs FDA-Approved Alternatives While you wait for retatrutide approval, two FDA-approved alternatives exist: semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro)
It's a proactive, systemic approach to wellness
SLU-PP-332 SLU-PP-332 is a small-molecule pan-agonist of estrogen-related receptors (ERR//) that stands out in preclinical studies for its exercise mimetic properties
The SURPASS-SEMA trial (NCT05583292) compared tirzepatide directly to semaglutide 1.0 mg in type 2 diabetes, showing tirzepatide 10 mg and 15 mg produced superior HbA1c and weight reductions [11]
Sharifian, A., Farahani, S., Pasalar, P., Gharavi, M